Ignite Creation Date:
2025-12-24 @ 1:47 PM
Ignite Modification Date:
2025-12-27 @ 4:07 PM
Study NCT ID:
NCT04045795
Status:
COMPLETED
Last Update Posted:
2025-09-12
First Post:
2019-08-02
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Multi-center, Open-label, Phase 1b Study in Patients With Relapsed/Refractory Multiple Myeloma (RRMM)
Sponsor:
Sanofi
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-08-06
Start Date Type:
ACTUAL
Primary Completion Date:
2024-03-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-03-27
Completion Date Type:
ACTUAL
First Submit Date:
2019-08-02
First Submit QC Date:
None
Study First Post Date:
2019-08-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-08
Last Update Post Date:
2025-09-12
Last Update Post Date Type:
ESTIMATED